Akamai Technologies dropped nearly 7% Thursday — the day after Q2 results landed — leaving the stock down 4% on the week at $110.54, and the post-print reaction has reshuffled the positioning picture in a hurry.
The most striking move is in options. Put demand has jumped to its highest level of the year relative to recent norms: the put/call ratio hit 0.56 on August 7, more than three standard deviations above its 20-day average of 0.28. That z-score of 3.0 is unusual for a large-cap internet infrastructure name — it points to traders buying downside protection at a pace rarely seen in the past twelve months, with the 52-week high for the PCR sitting at just 0.71. The earnings reaction itself feeds the context: the stock fell roughly 9.6% on August 6 following the Q2 print, a punishing single-session move that makes the hedging impulse easy to understand.
Short interest tells a building, rather than panicked, story. Bears have been quietly adding — SI has climbed to 13.9% of the free float, up 2.1% week-on-week and up 4.7% over the past month, with the absolute share count rising steadily from around 19.1 million in early July to just above 20 million. That is a meaningful level of short conviction, though the borrow market itself remains relaxed. Cost to borrow is running at just 0.44%, easing from 0.52% a week ago, and availability in the lending pool is ample at roughly 332% of shares already borrowed — well above the 52-week trough of 281%. New short positions face no friction in the borrow market. Positioning looks elevated rather than squeezed.
The Street's reaction to the earnings miss is mixed but telling. Analysts who were already cautious trimmed targets: RBC cut to $135 from $150, Piper Sandler moved to $140 from $156, and both maintained neutral-equivalent ratings. On the other side, bulls held their ground — Guggenheim raised its target to $190, and UBS lifted to $143 from $125 while keeping Neutral. The consensus remains "buy" across 11 buys and 8 holds, with a mean target near $160, implying roughly 44% upside from current levels. That gap is wide enough to suggest the Street still believes in the business; the question is one of timing and execution. The bear case centres on CDN commoditisation and the capital intensity of the hardware-as-a-service pivot. The bull case rests on the major customer contract expected to drive double-digit growth, combined with cybersecurity and cloud exposure. Factor scores lean cautious: the short score ranks in just the 13th percentile and the EPS momentum reading is in the 20th percentile over 90 days, reflecting the soft earnings backdrop. The days-to-cover rank at 18 similarly flags this as a name with meaningful short conviction relative to trading volume.
Insider activity does not add much signal here. The most recent trades on record — an EVP sale of 3,100 shares in July and smaller CMO and CTO disposals in June — are routine in size and low in significance, with no C-suite purchases visible in the 90-day window to counter the bearish read from the print.
The next scheduled earnings date is November 3, giving roughly three months for Akamai to demonstrate whether the new customer contract and the hardware-as-a-service revenues are gaining traction. Close peer DOCN rose 5.7% on the week while AKAM fell 4%, underscoring that the selloff is stock-specific rather than a sector rotation. What to watch from here: whether short interest continues to build above 14% of float as bears press the post-earnings weakness, and whether the options put/call ratio normalises back toward its 0.28 mean or sustains at elevated levels into the next data cycle.
See the live data behind this article on ORTEX.
Open AKAM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
